Title of article :
Single Nucleotide Polymorphisms at Erythropoietin, Superoxide Dismutase 1, Splicing Factor, Arginine/Serin-rich 15 and Plasmacytoma Variant Translocation Genes Association with Diabetic Nephropathy
Author/Authors :
Alwohhaib, Maisaa Kuwait University - Faculty of Allied Health Sciences, Health Science Center - Department of Medical Laboratory Sciences, Kuwait , Alwaheeb, Salah Kuwait University - Faculty of Medicine, Health Science Center - Department of Pathology, Kuwait , Alyatama, Nour Farwaniyah Hospital - Department of Internal Medicine, Kuwait , Dashti, Ali A. Kuwait University - Faculty of Allied Health Sciences, Health Science Center - Department of Medical Laboratory Sciences, Kuwait , Abdelghani, Amal Mubarak Al-Kabeer Hospital - Nephrology Department, Kuwait , Hussain, Naser Mubarak Al-Kabeer Hospital - Nephrology Department, Kuwait
Abstract :
A number of genes have been identified in diabetic nephropathy. Association between diabetes-associated nephropathy and polymorphisms in the erythropoietin (EPO) gene,variants in the superoxide dismutase 1 (SOD1) gene and plasmacytoma variant translocation 1 (PVT1) gene have been identified. The EPO,SOD1:SFRS15 and PVT1 genes were genotyped using the single nucleotide polymorphism (SNP) technique in 38 diabetic nephropathy patients (Group 1) compared with 64 diabetic type 2 subjects without nephropathy (Group 2) at the Mubarak Alkabeer Hospital,Kuwait. The frequency of the risk allele T of the EPO (rs1617640) gene was high in both groups (0.96 in Group 1 and 0.92 in Group 2). Similarly,SNPs of the PVT1 (rs2720709) gene showed a higher frequency of the risk allele G in both groups (0.70 in the Group 1 and 0.68 in Group 2). Although the frequency of the risk allele A was higher than the frequency of the non-risk allele C of the SOD1:SFRS15 gene in both groups,the lowest probability value was observed in those gene SNPs (P = 0.05). We observed that the A allele of the SOD1:SFRS15 gene (rs17880135) was more frequently present in Group 1 (0.75) compared with Group 2 (0.62). Susceptibility to diabetes-associated nephropathy is partially mediated by genetic predisposition,and screening tests may open the gate for new therapeutic approaches.